|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 10.34 USD | +7.31% |
|
-2.26% | +38.00% |
| 06-09 | Cartesian Therapeutics Signs Licensing Agreement With WestGene to Develop Therapies for Autoimmune Diseases | MT |
| 05-26 | Cartesian Therapeutics, Inc. Announces Executive Changes | CI |
Chart: Technical Analysis
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Bullish | Bullish | Neutral |
| Resistance | 10.18 | 10.18 | 13.33 |
| Spread/Res. | -2.26% | -2.26% | -25.36% |
| Spread/Supp. | +31.96% | +31.96% | +70.38% |
| Support | 7.54 | 7.54 | 5.84 |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Stocks
- RNAC Stock
- Charts Cartesian Therapeutics, Inc.
Select your edition
All financial news and data tailored to specific country editions
